Overall rank by patents
#44,998
of 49,997 tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 13 technology areas, recorded in grant years 2015–2015. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;).
The verdict
According to USPTO PatentsView, Axcelon ranks #44,998 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 13 technology areas.
USPTO PatentsView assignee plate
Corpus R44998 · Foreign Corporation #44,998 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: AVL Software and Functions GmbH (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Axcelon Biopolymers · this assignee
32 score
3D Lighting… · lowest
7 score
What this shows Axcelon's Innovation Score is 32.0/100 (40th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Axcelon Biopolymers Corporation is a focused PatentsView assignee: 13 CPC subclasses with 60% of grants classified under A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;). By volume, Axcelon sits between AVL Software and Functions GmbH and Aygaz Anonim Sirketi.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
AVL Software and Functions GmbH
5 patents
Avvio GMBH & Co KG
5 patents
Awds Technologies SRL
5 patents
AWE Technologies LLC
5 patents
Axcen Photonics Corp.
5 patents
AXIOM
5 patents
Axtone Spolka Akcyjna
5 patents
Aygaz Anonim Sirketi
5 patents
Axcelon Biopolymers Corporation
5 patents
What this shows Axcelon holds 5 patents at rank #44,702, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #44,702 in granted patent volume.
Other assignees with the most granted patents in Axcelon's primary technology class.
Axcelon's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
32 40th percentile higher than 40% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 100.0% |
Top 13 of 13 technology areas
Overall rank by patents
#44,998
of 49,997 tracked assignees
32.0 out of 100
What to do with this data
Axcelon Biopolymers Corporation's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.